BIOMAT Database Logo BIOMAT Database Logo

Oral and intravenous suppression tests in the diagnosis of Cushing's syndrome. 1965

V H James, and J Landon, and V Wynn

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010912 Pituitary-Adrenal Function Tests Tests that evaluate the adrenal glands controlled by pituitary hormones. Function Test, Pituitary-Adrenal,Function Tests, Pituitary-Adrenal,Pituitary Adrenal Function Tests,Pituitary-Adrenal Function Test,Test, Pituitary-Adrenal Function,Tests, Pituitary-Adrenal Function
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V H James, and J Landon, and V Wynn
Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing's syndrome.
January 1973, Acta endocrinologica,
V H James, and J Landon, and V Wynn
Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome.
November 1969, Annals of internal medicine,
V H James, and J Landon, and V Wynn
The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
July 2010, Clinical endocrinology,
V H James, and J Landon, and V Wynn
Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome.
January 2003, Journal of endocrinological investigation,
V H James, and J Landon, and V Wynn
Dexamethasone suppression test in diagnosis in Cushing's syndrome.
June 1962, British medical journal,
V H James, and J Landon, and V Wynn
Carbamazepine and false positive dexamethasone suppression tests for Cushing's syndrome.
February 2005, BMJ (Clinical research ed.),
V H James, and J Landon, and V Wynn
The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
August 1999, Clinical endocrinology,
V H James, and J Landon, and V Wynn
[The single dexamethasone suppression test in the diagnosis of Cushing's syndrome].
February 1968, Nordisk medicin,
V H James, and J Landon, and V Wynn
Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.
December 1960, The Journal of clinical endocrinology and metabolism,
V H James, and J Landon, and V Wynn
DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST.
August 1965, Archives of internal medicine,
Copied contents to your clipboard!